Fall in genital warts diagnoses in the general and indigenous australian population following implementation of a national human papillomavirus vaccination program: Analysis of routinely collected national hospital data

Journal of Infectious Diseases

Volumn 211, Issue 1, 2015, Pages 91-99

  Smith, Megan A ^a   Liu, Bette ^a,b   McIntyre, Peter ^c   Menzies, Robert ^c   Dey, Aditi ^c   Canfell, Karen ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SAX INSTITUTE   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Australia; condyloma acuminate; genital warts; herd effect; HPV; human papillomavirus; iepact; indigenous; vaccination

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; AUSTRALIAN; CERVICAL SCREENING; CHILD; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; INDIGENOUS PEOPLE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIVATE HOSPITAL; PUBLIC HOSPITAL; SCHOOL CHILD; SCREENING TEST; SEXUAL BEHAVIOR; VACCINATION; WART VIRUS; CONDYLOMATA ACUMINATA; HOSPITAL; IMMUNOLOGY; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PREVENTIVE HEALTH SERVICE; PROCEDURES; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUSTRALIA; CHILD; CONDYLOMATA ACUMINATA; FEMALE; HOSPITALS; HUMANS; IMMUNIZATION PROGRAMS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SEXUAL BEHAVIOR; VACCINATION; YOUNG ADULT;

EID: 84922429116     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu370     Document Type: Article

References (49)

1. Brotherton JM, Murray SL, Hall MA, et al. Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. Med J Aust 2013; 199:614-7
2. Brotherton J, Gertig D, Chappell G, Rowlands L, Saville M. Catching up with the catch-up: HPV vaccination coverage Data for Australian women aged 18-26 years from the National HPV Vaccination Program Register. Commun Dis Intell 2011; 35:197-201
3. Brotherton JM, Liu B, Donovan B, Kaldor JM, Saville M. Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: inDepenDent estimates from a nationally representative mobile phone survey. Vaccine 2014; 32:592-7
4. Forman D, De Martel C, Lacey CJ, et al. Global burDen of human papillomavirus and related diseases. Vaccine 2012; 30(suppl 5):F12-23
5. Garland SM, Steben M, Sings HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009; 199:805-14
6. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377:2085-92
7. Australian Institute of Health and Welfare. Cervical screening in Australia 2010-2011. Cancer series 76. Cat no. CAN 72. Cancer series. Canberra: AIHW, 2013
8. Gertig DM, Brotherton JM, Budd AC, Drennan K, Chappell G, Saville AM. Impact of a population-based HPV vaccination program on cervical abnormalities: a Data linkage study. BMC Med 2013; 11:227
9. Tabrizi SN, Brotherton JM, Kaldor JM, et al. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis 2012; 206:1645-51
10. Hariri S, Markowitz LE, Dunne EF, Unger ER. Population impact of HPV vaccines: summary of early eviDence. J Adolesc Health 2013; 53:679-82
11. Ali H, Donovan B, Wand H, et al. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance Data. BMJ 2013; 346:f2032
12. Donovan B, Franklin N, Guy R, et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance Data. Lancet Infect Dis 2011; 11:39-44
13. Liu B, Donovan B, Brotherton JML, Kaldor JM, Saville M. Genital warts and chlamydia in Australian women: comparison of national population-based surveys in 2001 and 2011. [Epub ahead of print]. Sex Transm Infect 2014. doi:10.1136/sextrans-2013-051307
14. Ali H, Guy RJ, Wand H, et al. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infect Dis 2013; 13:140
15. Australian Institute of Health and Welfare, Cancer Australia. Gynaecological cancers in Australia: An overview. Cancer series no. 70. Cat no. CAN 66. Canberra: AIHW, 2012
16. Australian Bureau of Statistics. 3238.0 Experimental Estimates and Projections, Aboriginal and Torres Strait IslanDer Australians, 1991 to 2021, 2009
17. Australian Institute of Health and Welfare. Indigenous iDentification in hospital separations Data-quality report. Health Services Series no. 35. Cat. no. HSE 85. Canberra: AIHW, 2010
18. Australian Institute of Health andWelfare. National Hospital Morbidity Database: scope of the Database. http://www.aihw.gov.au/Data-source/#scope. Accessed 24 October 2013
19. Australian Bureau of Statistics. 3101.0 Australian Demographic statistics, Canberra: ABS, 2013
20. Department of Health and Ageing. Immunise Australia Program-human papillomavirus (HPV). http://www.health.gov.au/internet/immunise/publishing.nsf/Content/immunise-hpv. Accessed 9 May 2013
21. Australian Institute of Health andWelfare. Improving the quality of Indigenous iDentification in hospital separations Data. AIHW cat. no. HSE 101. Canberra: AIHW (Health Services Series no. 25), 2005
22. Australian Institute of Health and Welfare. Indigenous iDentification in hospital separations Data-quality report. Cat. no. IHW 90. Canberra: AIHW, 2013
23. Palefsky JM. Human papillomavirus-related disease in men: not just a womens issue. J Adolesc Health 2010; 46:S12-9
24. Nyitray AG, Carvalho Da Silva RJ, Baggio ML, et al. Six-month inciDence, persistence, and factors associated with persistence of anal human papillomavirus inmen: the HPV inmen study. J Infect Dis 2011; 204:1711-22
25. National Health and Medical Research Council. Screening to prevent cervical cancer: guiDelines for the management of asymptomatic women with screen Detected abnormalities. Canberra: Commonwealth of Australia, 2005
26. National Cancer Institute. Joinpoint regression program. http://surveillance.cancer.gov/joinpoint/. Accessed 21 May 2014
27. KimHJ, FayMP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19:335-51
28. Brotherton J, Deeks S, Campbell-Lloyd S, et al. Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Commun Dis Intell Q Rep 2008; 32:457-61
29. Smith A, Agius P, Mitchell A, Barrett C, Pitts M. SeconDary stuDents and sexual health 2008. Monograph series no. 70. Melbourne: Australian Research Centre in Sex, Health and Society, La Trobe University, 2009
30. Dobson S, McNeil S, Dionne M, et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA 2013; 309:1793-802
31. Niccolai LM, Julian PJ, Meek JI, McBriDe V, Hadler JL, Sosa LE. Declining rates of high-graDe cervical lesions in young women in Connecticut, 2008-2011. Cancer EpiDemiol Biomarkers Prev 2013; 22:1446-50
32. Baandrup L, Blomberg M, Dehlendorff C, Sand C, AnDersen KK, Kjaer SK. Significant Decrease in the inciDence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program. Sex Transm Dis 2013; 40:130-5
33. Flagg EW, Schwartz R, Weinstock H. Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination. Am J Public Health 2013; 103:1428-35
34. Mikolajczyk RT, Kraut AA, Horn J, Schulze-Rath R, Garbe E. Changes in inciDence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-An ecologic study. Sex Transm Dis 2013; 40:28-31
35. Bauer HM, Wright G, Chow J. EviDence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims Data, 2007-2010. Am J Public Health 2012; 102:833-5
36. Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw C. Rapid Decline in presentations for genital warts after the implementation of a national quadrivalent human papillomavirus vaccination program for young women. Sex Transm Infect 2009; 85:499-502
37. Oliphant J, Perkins N. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services. N Z Med J 2011; 124:51-8
38. Leval A, Herweijer E, Arnheim-Dahlstrom L, et al. InciDence of genital warts in SweDen before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis 2012; 206:860-6
39. The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia. Annual surveillance report 2013. Sydney, NSW: The Kirby Institute, The University of New South Wales, 2013
40. Ali H, Guy RJ, Fairley CK, et al. UnDerstanding trends in genital Chlamydia trachomatis can benefit from enhanced surveillance: findings from Australia. Sex Transm Infect 2012; 88:552-7
41. Lim MS, El-Hayek C, Goller JL, et al. Trends in chlamydia positivity among heterosexual patients from the Victorian Primary Care Network for Sentinel Surveillance, 2007-2011. Med J Aust 2014; 200:166-9
42. OConnor CC, Ali H, Guy RJ, et al. High chlamydia positivity rates in Indigenous people attending Australian sexual health services. Med J Aust 2014; 200:595-8
43. Mitchell A, Patrick K, Heywood W, Blackman P, PittsM. National Survey of Australian SeconDary StuDents and Sexual Health 2013. In: Australian Research Centre in Sex, Health and Society. ARCSHS monograph series no. 97. Melbourne, Australia: La Trobe University, 2014
44. Grulich AE, De Visser RO, Smith AM, Rissel CE, Richters J. Sex in Australia: sexually transmissible infection and blood-borne virus history in a representative sample of adults. Aust N Z J Public Health 2003; 27:234-41
45. Pirotta M, Stein AN, Conway EL, Harrison C, Britt H, Garland S. Genital warts inciDence and healthcare resource utilisation in Australia. Sex Transm Infect 2010; 86:181-6
46. Leval A, Herweijer E, Ploner A, et al. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst 2013; 105:469-74
47. National Centre for Classification in Health (NCCH). Australian coding stanDard. 1st ed. NCCH: Sydney, 1998
48. National Centre for Classification in Health (NCCH). Australian coding stanDard. 3rd ed. NCCH: Sydney, 2002
49. National Centre for Classification in Health (NCCH). Australian coding stanDard. 7th ed. NCCH: Sydney, 2010